Highly suspicious activity going on. Desperate times call for desperate measures I guess. Big Pharma is scared. If monoclonal antibodies are the next generation of cancer treatment, how many product lines owned by Big Pharma are going to become obsolete? This is huge...Thomas Edison light bulb huge. It's the biggest threat the pharmaceutical industry has ever seen. Keeping Peregrines stock price depressed this low, it's pointless to partner with a company that could simply be bought outright. It's going to get interesting before the year is over.
They aren't short. They are paid bashers. Whether they actually know who's paying them or not, the big pharmaceutical companies want to keep this little gem depressed at all costs. No investor is going to spend that much time and effort posting on these boards unless they are being paid. Someone feels that keeping this stock down is of the highest priority and it's more than just a short tactic.
Has anyone noticed Yahoo has shut down the "message board" link from Peregrine's page? It's been shut down for about a week now. I had to link into the message board through my alerts. All other tickers I pull up have the "message board" link available on the left where it's always been. When the bashing wasn't getting the job done on the this board, Big Pharma pulled out yet another stop throwing some cash at Yahoo to shut down the link? Coincidence has to stop at some point. A key employee passes away within months of the Sunrise results? I think Bavi is as big as peanut oil and the diesel engine. Oil companies weren't going to let someone market an engine that ran off peanut oil and the poor guy wound up dead. This thing is that big and foul play wouldn't surprise me.
I linked in through one of my previous alerts...anytime someone responds to your post you get a little alert. I can link in through my alerts only. Yahoo has shut down the message board link on the main page for Peregrine. No other stocks have the message board link shut down that I've researched. If it were for just a day or two, I'd assume it was being updated or there was a glitch. It appears to be an intentional action. Did you bother to investigate the non existent link? I've been following PPHM for a few years and frequently read MB posts. I've never seen this issue last for more than a day or two with any ticker and when it did occur it affected all tickers.
Opening strong doesn't seem to get it done in the afternoon/close. If you track the MACD for this stock, the swings can be easily identified. We're approaching another buying sequence. On the upside, the last buying frenzy expanded quite a bit. It will be interesting to see the next wave of positive momentum and what limits it will tolerate. We may be at the beginning of price expansion with SUNRISE results expected in 3rd or 4th quarter. We are already in the second quarter. The biggest question I have is: Is enrollment complete for the SUNRISE trial? If not, how many more patients are required to complete it? 11-12 months following the last patient enrollment will be the target period for the much anticipated announcement. Investors, long and short, have to remember these monoclonal antibodies are being used to treat/test TERMINAL cancer patients. Tumors that have grown and spread are difficult to kill with anything. Early detection and monoclonal antibodies offer a new era of hope...not a cure...but something that's one hell of a lot smarter and more effective than anything that's out there now.
Did you see the free marketing from a few months ago from a newly approved inhalable insulin? If results of the phase 3 trial are inline with the phase 2 trial, every news network and radio station is going to be talking about it. If they can spool Avid up to meet Bavi's demand, a partner will not be necessary. This will be the only hurdle worth noting. I'm expecting a mass bidding war to occur between big Pharmaceutical companies for the acquisition of Peregrine the day the FDA approves Bavi for market. It could be as little as $6 to $9 a share or it could be $60 to $90 a share. Bavi is potentially the most versatile treatment application the pharmaceutical industry has ever seen. Breast and lung cancer trials have proven phenomenal so far. There are so many other possible ailments Bavi could address very effectively with minimal toxicity compared to anything that's out there now. When the FDA approves it, nobody and I mean nobody is going to care about the CEO's salary, share count, or other weaknesses within the company. This is a once in a lifetime opportunity for unheard of gains. Luckily the data mix up in phase 2 dropped this back down from $5. No placebo doubles MOS in a cancer patient. Take advantage of the stupidity of others.
Somebody contributes relatively non-biased information to this board that is of mature context and look at the peanut gallery's responses below. For the short term, I think the shrinking cash position on the balance sheet and timeline required to complete the SUNRISE trial are going to be the biggest set back for the company. I agree that the safety aspects for the first look in will not impose any type of threat what so ever. I don't think there's a cancer treatment out there with a better safety profile to Bavituximab.
So you are saying Bavi is getting approved? Cortara is a specific treatment for a specific type of cancer. Bavi is for all cancer types and does not require a complex delivery system. Almost non-existent toxicity as well. It won't ever make it to a shelf the demand will be so high.
With MOS at almost 12 months, I wouldn't expect the development of any endpoints with current enrollees to be reached until late this year.